Comparative study of cluster and conventional immunotherapy schedules with Dermatophagoides pteronyssinus in the treatment of persistent allergic rhinitis

International Archives of Allergy and Immunology

Volumn 148, Issue 2, 2009, Pages 161-169

  Zhang, Luo ^a,b   Wang, Chengshuo ^a   Han, Demin ^a,c   Wang, Xiangdong ^a   Zhao, Yan ^a   Liu, Jianhui ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b TIANJIN UNIVERSITY   (China)

^c BEIJING INSTITUTE OF OTOLARYNGOLOGY   (China)

Author keywords

Allergic rhinitis; Cluster immunotherapy; Conventional immunotherapy

Indexed keywords

HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; IMMUNOMODULATING AGENT; LORATADINE;

ADOLESCENT; ADULT; ALLERGIC RHINITIS; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATOPHAGOIDES PTERONYSSINUS; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; IMMUNOTHERAPY; INJECTION SITE REACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; ALLERGENS; ANIMALS; ANTIGENS, DERMATOPHAGOIDES; DERMATOPHAGOIDES PTERONYSSINUS; DESENSITIZATION, IMMUNOLOGIC; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; RHINITIS, ALLERGIC, PERENNIAL; SEVERITY OF ILLNESS INDEX; SKIN TESTS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 51849164024     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000155747     Document Type: Article

References (32)

1. Bousquet J, van Cauwenberge P, Bachert C, et al: Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108(suppl 5):S147-S334.
2. Sly RM: Changing prevalence of allergic rhinitis and asthma. Ann Allergy Asthma Immunol 1999;82:233-248.
3. Sly RM: Epidemiology of allergic rhinitis. Clin Rev Allergy Immunol 2002;22:67-103.
4. Linneberg A: Changes in atopy over 25 years: allergy epidemic has spread to old age. BMJ 2005;331:352.
5. Law M, Morris JK, Wald N, et al: Changes in atopy over a quarter of a century, based on cross-sectional data at three time periods. BMJ 2005;330:1187-1188.
6. Bachert C, van Cauwenberge P, Olbrecht J, et al: Prevalence, classification and perception of allergic and nonallergic rhinitis in Belgium. Allergy 2006;61:693-698.
7. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema. ISAAC: The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 1998;351:1225-1232.
8. Zhao T, Wang HJ, Chen Y, et al: Prevalence of childhood asthma, allergic rhinitis and eczema in Urumqi and Beijing. J Paediatr Child Health 2000;36:128-133.
9. Sporik R, Holgate ST, Platts-Mills TA, et al: Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood. A prospective study. N Engl J Med 1990;323:502-507.
10. Bousquet J, Lockey R, Malling HJ: Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol 1998;102:558-562.
11. Malling HJ: Immunotherapy as an effective tool in allergy treatment. Allergy 1998;53:461-472.
12. Varney VA, Tabbah K, Mavroleon G, et al: Usefulness of specific immunotherapy in patients with severe perennial allergic rhinitis induced by house dust mite: a double-blind, randomized, placebo-controlled trial. Clin Exp Allergy 2003;33:1076-1082.
13. Tabar AI, Fernandez-Tavora L, Alonso R, et al: Tolerance of a cluster schedule with a house dust mite extract quantified in mass units: multicenter study. J Investig Allergol Clin Immunol 2004;14:193-197.
14. Garcia-Robaina JC, Sanchez I, de la Torre F, et al: Successful management of mite-allergic asthma with modified extracts of Dermatophagoides pteronyssinus and Dermatophagoides farinae in a double-blind, placebo-controlled study. J Allergy Clin Immunol 2006;118:1026-1032.
15. Frew AJ, Powell RJ, Corrigan CJ, et al: Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006;117:319-325.
16. Calderon MA, Alves B, Jacobson M, et al: Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev 2007:CD001936.
17. Dursun AB, Sin BA, Oner F, et al: The safety of allergen immunotherapy (IT) in Turkey. J Investig Allergol Clin Immunol 2006;16:123-128.
18. Serrano P, Algorta J, Martinez A, et al: Prospective safety study of immunotherapy administered in a cluster schedule. J Investig Allergol Clin Immunol 2004;14:312-319.
19. Tabar AI, Echechipia S, Garcia BE, et al: Double-blind comparative study of cluster and conventional immunotherapy schedules with Dermatophagoides pteronyssinus. J Allergy Clin Immunol 2005;116:109-118.
20. Position paper: immunotherapy. (EAACI) The European Academy of Allergology and Clinical Immunology. Allergy 1993;48(suppl 14):7-35.
21. Colas C, Monzon S, Venturini M, et al: Double-blind, placebo-controlled study with a modified therapeutic vaccine of Salsola kali (Russian thistle) administered through use of a cluster schedule. J Allergy Clin Immunol 2006;117:810-816.
22. Juniper EF, Thompson AK, Ferrie PJ, et al: Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire. J Allergy Clin Immunol 1999;104:364-369.
23. Abramson MJ, Puy RM, Weiner JM: Allergen immunotherapy for asthma. Cochrane Database Syst Rev 2003:CD001186.
24. Cox L: Accelerated immunotherapy schedules: review of efficacy and safety. Ann Allergy Asthma Immunol 2006;97:126-137.
25. Alvarez-Cuesta E, Bousquet J, Canonica GW, et al: Standards for practical allergen-specific immunotherapy. Allergy 2006;61(suppl 82):1-20.
26. Greineder DK: Risk management in allergen immunotherapy. J Allergy Clin Immunol 1996;98:S330-S334.
27. Nielsen L, Johnsen CR, Mosbech H, et al: Antihistamine premedication in specific cluster immunotherapy: a double-blind, placebo-controlled study. J Allergy Clin Immunol 1996;97:1207-1213.
28. Casale TB, Busse WW, Kline JN, et al: Omalizumab pretreatment decreases acute reactions after rush immunotherapy for rag-weed-induced seasonal allergic rhinitis. J Allergy Clin Immunol 2006;117:134-140.
29. Ewbank PA, Murray J, Sanders K, et al: A double-blind, placebo-controlled immunotherapy dose-response study with standardized cat extract. J Allergy Clin Immunol 2003;111:155-161.
30. Durham SR, Till SJ: Immunologic changes associated with allergen immunotherapy. J Allergy Clin Immunol 1998;102:157-164.
31. Nanda A, O'Connor M, Anand M, et al: Dose dependence and time course of the immunologic response to administration of standardized cat allergen extract. J Allergy Clin Immunol 2004;114:1339-1344.
32. Lent AM, Harbeck R, Strand M, et al: Immunologic response to administration of standardized dog allergen extract at differing doses. J Allergy Clin Immunol 2006;118:1249-1256.